Garin and 9 others indicted by DOJ on reckless imprudence resulting to homicide over Dengvaxia

Garin and 9 others indicted by DOJ on reckless imprudence resulting to homicide over Dengvaxia

Slowly the arm of the law is catching up on those responsible for the Dengvaxia scandal that has rocked the country when the countrywide anti-dengue campaign was set into motion during the administration of former President Benigno “Noynoy” Aquino III.

The Department of Justice (DOJ) charged  former Secretary of Health and current Rep. Janette Garin (Iloilo, 1st District) and nine others on reckless imprudence resulting to homicide over the controversial anti-Dengue vaccine Dengvaxia.

In their press release, the DOJ said that state prosecutors found probable cause to indict Garin, former Health secretary, and officials of the Department of Health, Food and Drug Administration, Research Institute for Tropical Medicine and Sanofi Pasteur Inc. for reckless imprudence resulting to homicide.
Then DOH Secretary janette Garin with former President BS Aquino III,
during the mass vaccination of Dengue launch.
(photo credit to owner)

“The Panel [of prosecutors] concluded that the accomplishment of the procurement process for the Dengvaxia vaccine, with undue haste, within a limited timeframe, and despite the red flags known to Garin and other respondents, amounted to reckless imprudence,” DOJ said.
DOJ has reached the conclusion that the so-called miracle vaccine against Dengue was purchased by the Aquino administration and rolled out for use even though clinical trials for the vaccine were not yet completed.

“The panel found that there was no showing that the Dengvaxia vaccine had undergone [World Health Organization] prequalification at the time the FDA issued the [Certificate of Product Registration,” the release provided by Justice Assistant Secretary Neal Bainto read.

DOJ Prosecutors also said they found that the accused did not fully inform, and obtain the consent of, those who were vaccinated and their respective families of the “nature and risks” of Dengvaxia.

There was also no physical examination or health assessment of the kids before the inoculation of the vaccine, the DOJsaid.

Sanofi not off the hook

The DOJ indicted also the president of Sanofi Pasteur for violating the Consumer Act of the Philippines "for manufacturing the Dengvaxia vaccine which poses certain risks to seronegatives, or to those who have not previously contracted the Dengue disease."

“The Panel found that Sanofi indirectly admitted that Dengvaxia is a defective product due to the risk it poses to seronegatives,” it said.

Said act is in direct violation of the Article 97 of Republic Act 7394 or the Consumer Act of the Philippines that holds that a product is defective if “it does not offer the safety rightfully expected of it,” including “the use and hazards reasonably expected of it.”

State prosecutors “found that the circumstances surrounding the dispensation of the Dengvaxia vaccine made the same a mislabelled drug and held liable the President of Sanofi and four of its other officers or directors for violating the same act,” the statement read.

What can you say about this?

Share us your thoughts by simply leaving on the comment section below. For more news updates, feel free to visit our site often.

Stay updated with today's relevant news and trends by hitting the LIKE button.

Thanks for dropping by and reading this post.

Report from  PhilStar

Disclaimer: Contributed articles does not reflect the view of THE PH CHRONICLES. This website cannot guarantee the legitimacy of some of the information contributed to us. You may do additional research if you find some information doubtful. No part of this article maybe reproduced without permission from this website.

Post a Comment